AMAG Pharmaceuticals Retained Earnings Quarterly YoY Growth
AMAG Pharmaceuticals Historical Retained Earnings Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Sept. 30, 1995 | Go Pro |
| June 30, 1995 | Go Pro |
| March 31, 1995 | Go Pro |
| Dec. 31, 1994 | Go Pro |
| Sept. 30, 1994 | Go Pro |
| June 30, 1994 | Go Pro |
| March 31, 1994 | Go Pro |
| Dec. 31, 1993 | Go Pro |
| Sept. 30, 1993 | Go Pro |
| June 30, 1993 | Go Pro |
| March 31, 1993 | Go Pro |
| Dec. 31, 1992 | Go Pro |
| Sept. 30, 1992 | Go Pro |
| June 30, 1992 | Go Pro |
| March 31, 1992 | Go Pro |
| Dec. 31, 1991 | Go Pro |
| Sept. 30, 1991 | Go Pro |
| June 30, 1991 | Go Pro |
| March 31, 1991 | Go Pro |
| Dec. 31, 1990 | Go Pro |
| Sept. 30, 1990 | Go Pro |
| June 30, 1990 | Go Pro |
| March 31, 1990 | Go Pro |
| Dec. 31, 1989 | Go Pro |
| Sept. 30, 1989 | Go Pro |
| June 30, 1989 | Go Pro |
| March 31, 1989 | Go Pro |
| Dec. 31, 1988 | Go Pro |
| Sept. 30, 1988 | Go Pro |
| June 30, 1988 | Go Pro |
| March 31, 1988 | Go Pro |
| Dec. 31, 1987 | Go Pro |
| Sept. 30, 1987 | Go Pro |
| June 30, 1987 | Go Pro |
| March 31, 1987 | Go Pro |
| Dec. 31, 1986 | Go Pro |
| Sept. 30, 1986 | Go Pro |
| June 30, 1986 | Go Pro |
| March 31, 1986 | Go Pro |
| Dec. 31, 1985 | Go Pro |
| Sept. 30, 1985 | Go Pro |
About Retained Earnings Growth
Retained Earnings Growth is the percent increase/decrease of a company's retained net income over time. A company can use retained earnings to maintain current operations, or to invest in new ventures. Generally speaking, retained earnings growth is accompanied by subsequent increases in sales and profitability.
If a company's retained earnings at the end of 2008 were $12 million, and by the end of 2009 the company's retained earnings increased to $15 million, the company experienced a retained earnings growth of 25%.
Learn More
AMAG Retained Earnings Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| BioDelivery Sciences International | |
| Repligen Corporation | |
| Shire | 65.41% |
AMAG News
AMAG Pharmaceuticals' CEO Discusses Q1 2013 (Results - Earnings Call Transcript
Seeking Alpha Apr 23
Seeking Alpha Apr 23